• Profile
Close

Efficacy of misoprostol before diagnostic hysteroscopy in postmenopausal women: A randomized clinical trial

Menopause Jun 27, 2018

Nakano FA, et al. - In this randomized, double-blind, placebo-controlled clinical trial, researchers evaluated pain and determined the efficacy of misoprostol, compared with placebo, for postmenopausal women before diagnostic hysteroscopy. They analyzed 158 postmenopausal women who received either 200 μg of misoprostol or placebo through the vaginal route before diagnostic hysteroscopy (79 women/group). Outcomes suggested that misoprostol results in no reduction in pain intensity, the duration of the procedure, or need for additional cervical dilatation. in addition, more adverse effects were also noted with it when used in these women before diagnostic hysteroscopy
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay